Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
This trial was conducted in Europe, Middle East, North America and South America.
The aim of this trial was to compare the use of an intensified insulin treatment with insulin
aspart (NovoRapid®) versus human insulin (Actrapid®) in pregnancy.